Contact Us Register

Increasing patient awareness and rising demand for high quality care have made it imperative for healthcare providers to develop targeted therapies through specific and sensitive diagnostic tests. Clinical diagnostic tests are used to diagnose a medical condition, provide information about the patient’s health, or monitor a course of disease and assess the patient’s response to treatments. Various techniques... View more

Increasing patient awareness and rising demand for high quality care have made it imperative for healthcare providers to develop targeted therapies through specific and sensitive diagnostic tests. Clinical diagnostic tests are used to diagnose a medical condition, provide information about the patient’s health, or monitor a course of disease and assess the patient’s response to treatments. Various techniques of clinical diagnostic testing include blood gas testing, clinical chemistry, immunoassay, coagulation testing, hematology, polymerase chain reaction (PCR), and staining method.

Typically, clinical diagnostic tests involve use of antibody-based techniques for recognizing proteins or disease markers. However, these immunoassays cannot identify all biomarkers in one test and are prone to false-positive and false-negative results. Therefore, there is growing demand for more accurate, efficient, and reliable technologies. This has led to development of alternative testing methods such as LC-MS and GC-MS. However, high initial capital investment and lack of skilled labor is deterring adoption of advance testing devices. Major instruments used in clinical diagnostics include immunoassay analyzer, HPLC system, chemical analyzer, mass spectrometer (MS), LC-MS, and GC-MS. The use of reagents has simplified the testing practice and workflow for personnel in diagnostic laboratories.

New Techniques in Use

Molecular diagnostics is driving growth of the personalized medicine market which involves co-development of drugs/devices and specialized diagnostic tests. The technique is also referred to as companion diagnostic and can be used for toxicity studies, dose selection, monitoring patient response, and patient stratification.

Rapid diagnostic tests are performed at the physician office laboratory (POL), hospitals, health centers and home care. Demand for these tests is increasing rapidly owing to faster and accurate results. Tests have been developed for HbA1c testing, drug abuse, pregnancy testing, micro albumin, creatinine, blood gases, RSV, etc.

Demand for In-vitro diagnostics (IVD) is increasing in emerging markets such as India, China, Brazil, and South Korea. In-vitro diagnostic techniques have transformed the diagnostics industry by eliminating the complex in-vivo testing methods. The IVD techniques include the advance PCR technique, assays and hematology testing, helps diagnose and monitor patient’s health condition using samples of blood, cells or tissues.

Immunoassay diagnostics is expected to be driven by technological advancements such as novel biomarkers, ultrasensitive detection system and assays.

Fragmented Market

The diagnostic landscape, especially in the emerging countries, is highly fragmented and marked by the strong presence of unorganized diagnostic labs. Global players are now building global networks by investing in foreign markets. Moreover, in terms of manufacturers, the market is fragmented in a similar manner with many small players dominating local markets. Owing to the increasing demand for home care, manufacturers and diagnostic laboratories need to work in collaboration to provide quality care at patient convenience.

Conclusion

Increasing healthcare costs is deterring patients from undergoing regular health tests that can be improved with a wider insurance coverage. Inadequate insurance coverage in emerging economies is restricting patients from undergoing expensive health tests, thus fueling the market growth. Moreover, centralization of testing laboratories is projected to drive demand for high volume instrumentation and automation equipment. Demand for IVD tests from Asia Pacific, Latin America and the Middle East markets is also increasing rapidly.View less

Clinical Diagnostic Published Insights

Coherent Market Insights Glycated Albumin Assay Market

Published Date : Feb 2023

Diabetes mellitus is a chronic metabolic disease with a high incidence worldwide. Glycated hemoglobin (A1C) is the reference test for long-term glucose monitoring and has been shown to be associated with chronic complications of diabetes. However, A1C is not recommend... View more

Coherent Market Insights Clinical Diagnostic Market

Published Date : Jan 2023

Clinical diagnostic is the process of identifying a disease, condition, or injury based on the signs & symptoms a patient is having and patient's health history and physical exam. Clinical diagnostics have been also found to be valuable for the prevention, detecti... View more

Coherent Market Insights Metabolomics Market

Published Date : Dec 2022

Metabolomics is defined as the large scale study of all small molecules, commonly known as metabolites, within cells, biofluids, tissues or organisms. It is the study of substrates and products of metabolism. Metabolomics is an evolving field to comprehensively identi... View more

Coherent Market Insights Non Invasive Prenatal Testing Nipt Market

Published Date : Oct 2022

Noninvasive prenatal testing (NIPT) is also known as noninvasive prenatal screening (NIPS). It is a procedure used to determine the chromosomal abnormalities or disorders of the fetus which generally occur due to missing or an extra copy (aneuploidy) of a chromosome. ... View more

Coherent Market Insights Asia Pacific Newborn Screening Market

Published Date : Aug 2022

Newborn screening is a preventative public health initiative which allows detection of disorders early in life before clinical features are present. New-born screening allows these conditions to be detected at birth, allowing the child to potentially lead a normal and... View more

Coherent Market Insights Malaria Diagnostics Market

Published Date : Jul 2022

Malaria is a disease caused by plasmodium parasite, transmitted by bite of infected mosquitoes. When it bites, the mosquito injects malaria parasites into the blood. The severity of malaria varies based on the species of plasmodium. The majority of victims are young c... View more

Coherent Market Insights Enzyme Linked Immunosorbent Assay Market

Published Date : Jul 2022

Enzyme Linked Immunosorbent Assay (ELISA) is an immunoassay used to identify proteins, peptides, antibodies, and hormones. ELISA assay has application in biotechnology medicine, as a diagnostic tool, which detects color change to identify a target substance and measur... View more

Coherent Market Insights Animal Model Market

Published Date : Jun 2022

An animal model is a non-human species used in biomedical research because it can mimic aspects of a biological process or disease found in humans. Animals are essential for research that seeks to understand disease progression and treatments. These models are being u... View more

Coherent Market Insights Mexico In Vitro Diagnostics Market

Published Date : Jun 2022

Healthcare providers rely on a variety of tools to diagnose various diseases or conditions and guide treatment decisions. Among the most common and widely used are in vitro diagnostics (IVDs). IVD helps detect diseases or infections, and can be used to monitor overall... View more

Coherent Market Insights North Africa Non Invasive Prenatal Testing Market

Published Date : Feb 2022

Noninvasive prenatal testing (NIPT) is also known as noninvasive prenatal screening (NIPS). It is a procedure used to determine the chromosomal abnormalities or disorders of the fetus which generally occur due to missing or an extra copy (aneuploidy) of a chromosome. ... View more

Coherent Market Insights Trypsin Market

Published Date : Jan 2022

Trypsin is a proteolytic enzyme that aids in digestion. Inactive trysinogen formed by the pancreas gets converted into active trypsin in the small intestine. Trypsinogen, along with other proetinases like pepsin and chymotrypsin, breaks down protein from food into ami... View more

Coherent Market Insights Healthcare Testing Services Market

Published Date : Dec 2021

Healthcare testing services are invented, and developed in the laboratories. During pharmaceutical production and research and development, healthcare testing in labs is required at practically every stage including preclinical, clinical, and manufacturing. It is used... View more

Coherent Market Insights Pyrogen Testing Market

Published Date : Nov 2020

Pyrogen testing is detection of pyrogen in pharmaceutical drugs and devices. The contaminated devices or drugs when introduced in body can cause fever, shock, inflammation, and other problems. Pyrogen testing consists of kits, reagents, and instruments, which enable p... View more

Coherent Market Insights Enteric Disease Testing Market

Published Date : Aug 2020

Enteric infection is a type of intestinal disease that causes symptoms ranging from mild gastroenteritis to systemic infections and severe diarrhea. According to WHO in 2017, Infectious gastroenteritis accounts for 1 billion cases of diarrhea globally and over 2 milli... View more

Coherent Market Insights Hba1c Testing Devices Market

Published Date : May 2020

Hemoglobin A1c Testing Devices are used for diagnosis and monitoring of type 1 and type 2 diabetes. Hemoglobin A1c test results reflect the average blood sugar levels of an individual for the past two to three months. Increasing prevalence of diabetes is expected to p... View more

Coherent Market Insights Sarcoma Biopsy Market

Published Date : May 2020

Sarcoma is a type of cancer, which occurs in connective tissues. Moreover, sarcoma is broadly classified into two types such as soft tissue sarcoma and bone sarcoma. Soft tissue sarcomas occur in tissues of blood vessels, nerves, tendons, muscles, fat, and lining of t... View more

Coherent Market Insights Hospital Acquired Disease Testing Market

Published Date : Apr 2020

Hospital-acquired infections are acquired by the patient under medical care. The most common types of hospital-acquired infections are urinary tract infections, bloodstream infections, Methicillin-resistant Staphylococcus aureus (MRSA), pneumococcal infections, and ga... View more

Coherent Market Insights Liquid Biopsy Market

Published Date : Feb 2020

Liquid biopsy is an advanced non-invasive cancer diagnostic technique that uses bio-fluids such as blood, cerebrospinal fluid (CSF), plasma, and urine for detecting cancer. Liquid biopsy uses ... View more

LogoCredibility and Certifications

Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.

Reliability and Reputation

860519526
Reliability and Reputation
ISO 9001:2015

9001:2015
ISO 27001:2022

27001:2022
Reliability and Reputation
Reliability and Reputation
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.